Dawn Parsell Otto, EVP, Clinical Development at Tricida, Inc. (TCDA), sold 6,721 shares at $31.78 ($214K) on 2020-03-02, disclosed to the SEC on 2020-03-04.
Open-market sale of $214k TCDA by EVP, Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.78 | 2,994 | $95K | 44.5% |
| 2 | $31.78 | 2,994 | $95K | 44.5% |
| 3 | $31.98 | 210 | $7K | 3.1% |
| 4 | $31.98 | 523 | $17K | 7.8% |
| Total | $31.80 avg | 6,721 | $214K | 100% |
| Filing → |
| TCDA | SELL | 2020-04-30 | $172K | — | Filing → |
| TCDA | SELL | 2020-02-05 | $242K | — | Filing → |
| TCDA | SELL | 2020-01-06 | $227K | — | Filing → |